AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 NOV 14 - (NewsRx.com & NewsRx.net) -- VaxGen Inc. (VXGN) and the city of Incheon, South Korea, have signed an agreement that provides VaxGen land on which to construct a facility to manufacture the company's AIDS vaccine. This agreement is the first step in VaxGen's program to create capacity for global supplies of the vaccine, AIDSVAX, if it proves successful in Phase III trials and gains regulatory approval.
The agreement provides VaxGen with approximately 26 acres free of charge for 10 years in Songdo Industrial Park, which is being developed by Incheon Metropolitan City. The site, which is near the new Seoul/Incheon International Airport, includes room for pharmaceutical manufacturing facilities, administrative offices, and a research and development center. Incheon is located about an hour from Seoul on the country's west coast.
"In view of the advanced stage of our pivotal trials, VaxGen has placed a priority on establishing manufacturing capacity," said Lance K. Gordon, PhD, VaxGen's chief executive officer. "We believe having a large-scale manufacturing facility under our control would provide a consistent supply of AIDSVAX to help address worldwide ...
Source: HighBeam Research, VaxGen To Manufacture AIDS Vaccine In South Korea.(Brief Article)